1985
DOI: 10.1007/bf01983126
|View full text |Cite
|
Sign up to set email alerts
|

Rat mast cell activation and inactivation: Differences when various ligands are used to induce secretion

Abstract: The relationship between rat peritoneal mast cell activation and inactivation (desensitization) was studied for a variety of stimuli acting via IgE and IgG receptors on the cell surface. Anti-IgE, antigen (ovalbumin), anti-IgG1, anti-IgG2a and dimers, trimers and higher oligomers of IgE were used to induce histamine release from rat mast cells. All produced similar characteristics of cell activation, with a rapid rate of histamine release from the cells, release being 90% complete within 5 minutes and with cal… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1985
1985
2013
2013

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 17 publications
0
2
0
Order By: Relevance
“…For total (100%) release measurements, mast cells were lysed with 10% Triton X-100 and untreated control cell supernatant served as 0% release control. In vivo mast cell activation was determined in C57Bl/6 mice and mast cell defi cient Kit(W Ϫ sh /W Ϫ sh ) mice that had received intraperitoneal IgE receptor by multiple IgE molecules ( 8 ), neurogenic stimulation ( 8,9 ), infl ammatory stimuli (e.g., tumor necrosis factor ␣ and IL-1), and complement factors (e.g., C3a and C5a) ( 10 ). Although the endogenous triggers for mast cell activation in atherosclerosis are still unknown, IgE ( 11 ), IgG-oxidized low-density lipoprotein (oxLDL) immune complexes ( 12 ), the neuropeptide substance P ( 9,13 ), and the complement system ( 14 ) were suggested to activate mast cells in atherosclerosis.…”
Section: Cell Culturementioning
confidence: 99%
“…For total (100%) release measurements, mast cells were lysed with 10% Triton X-100 and untreated control cell supernatant served as 0% release control. In vivo mast cell activation was determined in C57Bl/6 mice and mast cell defi cient Kit(W Ϫ sh /W Ϫ sh ) mice that had received intraperitoneal IgE receptor by multiple IgE molecules ( 8 ), neurogenic stimulation ( 8,9 ), infl ammatory stimuli (e.g., tumor necrosis factor ␣ and IL-1), and complement factors (e.g., C3a and C5a) ( 10 ). Although the endogenous triggers for mast cell activation in atherosclerosis are still unknown, IgE ( 11 ), IgG-oxidized low-density lipoprotein (oxLDL) immune complexes ( 12 ), the neuropeptide substance P ( 9,13 ), and the complement system ( 14 ) were suggested to activate mast cells in atherosclerosis.…”
Section: Cell Culturementioning
confidence: 99%
“…Considering the unexpected results, other experiments concerning cross-linking and internalization which were almost all performed with RBL-cells and/or a monomeric loading with IgE should probably be repeated with ex vivo cells. It seems that there are indeed differences between the stimulation of ex vivo mast cells with allergen, anti-IgE or IgE-dimer [29,30]. The resistance of basophils to the AT was quite unexpected after the results for the hybridoma cell lines.…”
Section: Human Basophils Are Not Affected By the Toxicity Of Allergenmentioning
confidence: 99%